Responses
Gastroenterology and hepatology
Protocol
Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study
Compose a Response to This Article
Other responses
No responses have been published for this article.